Cinderbio
Founded 2012 · 5 employees on LinkedIn · 1 known investors
CinderBio develops HyperThermoacidic Archaeal Proteases (HTA-Proteases) for proteomics research, enzymes that function at high temperature and low pH to enable rapid, single-step sample preparation before LC-MS/MS analysis. Its products serve scientists in bottom-up, high-throughput, and clinical proteomics workflows for applications such as de novo antibody sequencing and biomarker discovery.
Investors · 1
Frequently asked questions
- What does Cinderbio do?
- CinderBio develops HyperThermoacidic Archaeal Proteases (HTA-Proteases) for proteomics research, enzymes that function at high temperature and low pH to enable rapid, single-step sample preparation before LC-MS/MS analysis. Its products serve scientists in bottom-up, high-throughput, and clinical proteomics workflows for applications such as de novo antibody sequencing and biomarker discovery.
- Who are Cinderbio's investors?
- Cinderbio's investors include Mount Wilson Ventures.